Variant Annotation ID	Variant/Haplotypes	Drug(s)	Phenotype Category	Significance	Sentence	Allele Of Frequency In Cases	Allele Of Frequency In Controls	P Value	Ratio Stat Type	Ratio Stat	Confidence Interval Start	Confidence Interval Stop
1451350980	rs4680	opioids	Dosage	yes	Genotypes AA + AG is associated with increased dose of opioids in people with Pain as compared to genotype GG.	A		= 0.043				
1451352120	rs6517442	opioids	Dosage	yes	Genotype CC is associated with increased dose of opioids in people with Low Back Pain as compared to genotypes CT + TT.	C		= 0.008				
1451354760	rs4149056	hmg coa reductase inhibitors	Efficacy	no	Genotypes CC + CT are not associated with decreased response to hmg coa reductase inhibitors as compared to genotype TT.			= 0.59				
1448257830	rs13242904	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.239	OR			
1448257821	rs9648623	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.255	OR			
1448257812	rs6969971	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.631	OR			
1448257803	rs13222222	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.346	OR			
1448257794	rs10226865	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.814	OR			
1448257785	rs4725061	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.441	OR			
1448257776	rs7801924	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.090	OR			
1448257767	rs10435183	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.866	OR			
1448257758	rs13245462	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.412	OR			
1448257749	rs10243846	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.447	OR			
1448257740	rs13239966	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.557	OR			
1448257731	rs10229643	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.452	OR			
1448257722	rs1476823	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.751	OR			
1448257713	rs17141876	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.747	OR			
1448257704	rs2041362	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.287	OR			
1448257686	rs37990	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.186	OR			
1448257677	rs7800750	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.542	OR			
1448257668	rs12537880	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.407	OR			
1448257657	rs715377	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.357	OR			
1448257646	rs7792118	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.610	OR			
1448257635	rs37976	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.918	OR			
1448257622	rs37973	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.401	OR			
1448257599	rs37972	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.357	OR			
1448995416	CYP2D6 poor and ultrarapid metabolizers	opioids	Efficacy	yes	CYP2D6 poor and ultrarapid metabolizers are associated with decreased response to opioids in people with Pain as compared to CYP2D6 intermediate metabolizer and normal metabolizer.			= 0.02	OR	2.63	1.19	5.83
1448995416	CYP2D6 poor and ultrarapid metabolizers	opioids	Efficacy	yes	CYP2D6 poor and ultrarapid metabolizers are associated with decreased response to opioids in people with Pain as compared to CYP2D6 intermediate metabolizer and normal metabolizer.			= 0.1	OR	2.15	0.87	5.32
1444702155	rs2770150	Pertussis vaccines	Efficacy	yes	Genotype GG is associated with decreased response to Pertussis vaccines in children as compared to genotype AG.	A		= 0.04	OR			
1450928977	rs1277441	opioids	Dosage	yes	Genotypes AG + GG are associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype AA.	G		= 0.013				
1446897429	rs1128503	glucocorticoids	Efficacy	yes	Genotype GG is associated with decreased response to glucocorticoids in people with Crohn Disease.	G	G	= 0.019	OR	6.583	1.76	24.628
1450928984	rs1277441	opioids	Dosage	no	Genotype GG is associated with decreased response to opioids in people with Neoplasms and Pain as compared to genotypes AA + AG.	G		= 0.055				
1450928995	rs795484	opioids	Dosage	yes	Genotype TT is associated with decreased response to opioids in people with Neoplasms and Pain as compared to genotypes CC + CT.	T		= 0.021				
1446897438	rs1045642	glucocorticoids	Efficacy	yes	Genotype GG is associated with decreased response to glucocorticoids in people with Crohn Disease.	G	G	= 0.009	OR	3.873	1.578	9.506
1450929002	rs795484	opioids	Dosage	yes	Genotypes CT + TT are associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype CC.	T		= 0.004				
1450945340	rs1047303	glucocorticoids	Efficacy	yes	Genotypes AA + AC are associated with increased resistance to glucocorticoids in people with Asthma as compared to genotype CC.			< 0.001				
1450945340	rs1047303	glucocorticoids	Efficacy	yes	Genotypes AA + AC are associated with increased resistance to glucocorticoids in people with Asthma as compared to genotype CC.			= 0.001				
1447814565	rs1516338	antidepressants	Efficacy	yes	Genotype TT is associated with increased response to antidepressants in people with Bipolar Disorder, Depressive Disorder or Depressive Disorder, Major as compared to genotype CC.			= 0.05	OR			
982028484	rs352046	hmg coa reductase inhibitors	Efficacy	yes	Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Acute coronary syndrome as compared to genotypes CG + GG.	G			Unknown			
769146107	rs2781659	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.			= 0.003	Unknown			
769146107	rs2781659	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.			= 0.029	Unknown			
769146107	rs2781659	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.			= 0.03	Unknown			
769146107	rs2781659	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.			= 0.047	Unknown			
769146107	rs2781659	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele A is associated with increased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele G.			= 0.31	Unknown			
1446896624	CYP2D6 poor metabolizers	antidepressants	Dosage	no	CYP2D6 poor metabolizers are not associated with dose of antidepressants in people with as compared to CYP2D6 normal metabolizers.				OR			
1450372709	rs7905446	Selective serotonin reuptake inhibitors	Efficacy	yes	Genotype TT is associated with decreased response to Selective serotonin reuptake inhibitors in people with Depression as compared to genotypes GG + GT.			= 0.0169	OR	1.976		
1446896239	rs291028	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.			= 5.02E-6	OR	0.61		
1446896245	rs7051085	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 5.51E-6	OR	0.63		
1446896253	rs1210638	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.			= 6.04E-6	OR	1.33		
1184997409	rs445925	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G.			= 8.52e-29	OR			
1184997409	rs445925	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G.	A		= 1.58e-18	OR			
1184997409	rs445925	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with increased response to hmg coa reductase inhibitors as compared to allele G.	A		= 1.41e-15	OR			
1446896207	rs10954808	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 1.20E-6	OR	0.73		
1446896213	rs506546	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.			= 1.46E-6	OR	0.76		
1446896227	rs72772787	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.			= 3.96E-6	OR	2.34		
1446896221	rs74546197	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 3.21E-6	OR	0.46		
1446896233	rs2043144	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.			= 4.30E-6	OR	0.38		
1446896179	rs74378198	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 3.77E-6	OR			
1446896173	rs7485210	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 3.42E-6	OR			
1446896187	rs4236420	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 4.08E-6	OR			
1446896193	rs2456568	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 5.03E-8	OR	1.36		
1446896199	rs113889867	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 8.68E-7	OR	0.51		
1446896143	rs4615376	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 1.05E-6	OR			
1446896151	rs2566255	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 1.51E-6	OR			
1446896157	rs910039	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 2.11E-6	OR			
1446896165	rs17068112	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.			= 3.28E-6	OR			
1446896111	rs2218603	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	G	= 3.28E-5	OR	1.54		
1446896123	rs6889896	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 5.49E-7	OR			
1446896117	rs1596996	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	T	C	= 3.63E-5	OR	1.53		
1446896129	rs35806662	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 6.47E-7	OR			
1446896135	rs73069924	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 8.09E-7	OR			
1184997431	rs646776	hmg coa reductase inhibitors	Efficacy	yes	Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T.			= 1.05e-9	OR			
1184997431	rs646776	hmg coa reductase inhibitors	Efficacy	yes	Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T.	C		= 6.7e-7	OR			
1184997431	rs646776	hmg coa reductase inhibitors	Efficacy	yes	Allele C is associated with increased response to hmg coa reductase inhibitors as compared to allele T.	C		= 2.43e-4	OR			
1446896077	rs2377898	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	G	= 1.34E-5	OR	0.65		
1184997420	rs10455872	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.			= 7.41e-44	OR			
1184997420	rs10455872	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.	A		= 7.14e-35	OR			
1184997420	rs10455872	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.	A		= 1.95e-11	OR			
1446896085	rs17220479	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	T	C	= 1.42E-5	OR	0.34		
1446896099	rs12729349	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	G	= 2.02E-5	OR	0.52		
1446896093	rs16871297	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	G	A	= 1.42E-5	OR	0.34		
1446896047	rs1470108	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	A	C	= 6.67E-6	OR			
1446896054	rs11811628	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	A	G	= 7.50E-6	OR			
1446896063	rs1466882	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	C	A	= 1.23E-5	OR	1.55		
1446896070	rs13015447	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	A	C	= 1.34E-5	OR	1.57		
1446896014	rs10512361	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	C	T	= 2.61E-6	OR			
1446896021	rs2453488	Selective serotonin reuptake inhibitors	Efficacy	no	Allele T is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	T	C	= 3.51E-6	OR			
1446896040	rs239022	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	G	= 4.82E-6	OR			
1446895992	rs16855294	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	C	A	= 8.82E-7	OR			
1445585200	rs767455	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotype CC.	C		< 0.05	OR			
1450373368	rs6265	antipsychotics	Efficacy	no	Allele C is not associated with response to antipsychotics in people with schizoaffective disorder or Schizophrenia as compared to allele T.			> 0.05	OR			
1446895979	rs11989215	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	G	A	= 7.46E-7	OR			
1446895979	rs11989215	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.	G	A	= 6.70E-6	OR	0.62		
1446895972	rs9328202	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	A	C	= 6.15E-7	OR			
827690019	rs2239179	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.			= 0.009	Unknown			
827690011	rs1540339	selective beta-2-adrenoreceptor agonists	Efficacy	yes	Allele C is associated with decreased response to selective beta-2-adrenoreceptor agonists in people with Asthma as compared to allele T.			= 0.02	Unknown			
1448603895	rs2289656	antidepressants	Efficacy	no	Allele G is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele A.	G			OR			
1448603878	rs2289657	antidepressants	Efficacy	no	Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele C.	A			OR			
1449714054	rs7432211	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.017	OR			
1449714054	rs7432211	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.971	OR			
1448603851	rs2289658	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C			OR			
1449714076	rs4912522	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.026	OR			
1449714076	rs4912522	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.866	OR			
1449714083	rs1800545	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.020	OR			
1449714083	rs1800545	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.646	OR			
1449714090	rs11195419	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.038	OR			
1449714090	rs11195419	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.521	OR			
1448603822	rs1778933	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C			OR			
1449714116	rs7943062	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.033	OR			
1449714116	rs7943062	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.516	OR			
1448603809	rs1187352	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C			OR			
1449714123	rs4646312	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.005	OR			
1449714123	rs4646312	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.804	OR			
1449714097	rs4274224	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.033	OR			
1449714097	rs4274224	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.699	OR			
1449714104	rs11214763	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.028	OR			
1449714104	rs11214763	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.941	OR			
1449714143	rs533123	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	G		= 0.460	OR			
1449714143	rs533123	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	G		= 0.758	OR			
1449714151	rs678849	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.028	OR			
1449714151	rs678849	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.090	OR			
1449714130	rs4680	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.026	OR			
1449714130	rs4680	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.545	OR			
1449173486	rs4680	opioids	Dosage	yes	Genotype GG is associated with increased dose of opioids in people with Pain, Postoperative as compared to genotype AA.	G		= 0.02	OR			
1444704305	rs1061631	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.			= 0.59	OR	1.18	0.65	2.15
1444704305	rs1061631	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AG + GG.			= 0.79	OR	1.07	0.65	1.77
1449173493	rs4818	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain, Postoperative as compared to allele G.	G		= 0.20	OR			
1444704313	rs1061624	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	no	Genotype GG is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.028	OR	2.94	1.16	7.46
1444704313	rs1061624	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	no	Genotype GG is not associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.040	OR	3.37	1.02	11.1
1449714159	rs2236857	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.044	OR			
1449714159	rs2236857	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.874	OR			
1449714210	rs4439987	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.776	OR			
1449714210	rs4439987	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.907	OR			
1449714217	rs6546952	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.161	OR			
1449714217	rs6546952	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.941	OR			
1449714203	rs881	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele C.	G		= 0.635	OR			
1449714203	rs881	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele C.	G		= 0.897	OR			
1449714238	rs3771836	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.156	OR			
1449714238	rs3771836	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.189	OR			
982025810	rs4680	antipsychotics	Efficacy	no	Allele G is not associated with response to antipsychotics in people with Schizophrenia as compared to allele A.				Unknown			
1449714246	rs10191107	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.026	OR			
1449714246	rs10191107	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.576	OR			
1449714224	rs2160652	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.274	OR			
1449714224	rs2160652	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.349	OR			
1449714231	rs12475818	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.121	OR			
1449714231	rs12475818	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.998	OR			
1444704274	rs3397	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.			= 0.018	OR	1.55	1.08	2.22
1444704274	rs3397	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele T.			= 0.036	OR	1.56	1.03	2.37
1449714283	rs2606731	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.661	OR			
1449714283	rs2606731	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.861	OR			
1444704286	rs1061622	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes GT + TT.			= 0.0085	OR	3.84	1.45	10.22
1444704286	rs1061622	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes GT + TT.			= 0.019	OR	4.19	1.19	14.7
1449714253	rs12713837	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.105	OR			
1449714253	rs12713837	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.805	OR			
982025799	rs4633	antipsychotics	Efficacy	no	Allele T is not associated with response to antipsychotics in people with Schizophrenia as compared to allele C.				Unknown			
1449714260	rs6725334	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.225	OR			
1449714260	rs6725334	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.437	OR			
1444704297	rs3397	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes CT + TT.			= 0.014	OR	2.34	1.21	4.5
1449714267	rs2024512	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.390	OR			
1449714267	rs2024512	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.546	OR			
1449714306	rs346070	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.161	OR			
1449714306	rs346070	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.489	OR			
1449714290	rs346076	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.338	OR			
1449714290	rs346076	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.707	OR			
1448423378	rs11591741	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele C.			= 0.041	OR	0.85	0.6	1.2
1449714297	rs901865	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.287	OR			
1449714297	rs901865	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.294	OR			
1449714333	rs9817063	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.798	OR			
1449714333	rs9817063	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.879	OR			
1449714340	rs3732790	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.821	OR			
1449714340	rs3732790	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.903	OR			
1449714347	rs963468	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.654	OR			
1449714347	rs963468	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.674	OR			
1449714326	rs2399496	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.556	OR			
1449714326	rs2399496	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.682	OR			
1449714368	rs6280	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.497	OR			
1449714368	rs6280	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.784	OR			
1449714375	rs324026	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.202	OR			
1449714375	rs324026	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.764	OR			
1449714407	rs939334	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.167	OR			
1449714407	rs939334	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.990	OR			
1448111986	rs3794271	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	no	Allele G is not associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid.			= 0.74	OR	1.01	0.84	1.22
1449714428	rs7621975	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.530	OR			
1449714428	rs7621975	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.910	OR			
1043859264	rs1801253	catecholamines	Dosage	yes	Genotype CC is associated with decreased dose of catecholamines in people with Coronary Artery Disease as compared to genotypes CG + GG.	C		< 0.05	Unknown			
1449714414	rs6792482	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.462	OR			
1449714414	rs6792482	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.644	OR			
1449714421	rs6443930	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.609	OR			
1449714421	rs6443930	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.947	OR			
1449714463	rs6807670	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.704	OR			
1449714463	rs6807670	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.985	OR			
1449714449	rs6766410	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.602	OR			
1449714449	rs6766410	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele C.	C		= 0.853	OR			
1449714456	rs6807362	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.172	OR			
1449714456	rs6807362	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.557	OR			
1449714495	rs1423691	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.080	OR			
1449714495	rs1423691	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.329	OR			
1449714478	rs6443950	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.155	OR			
1449714478	rs6443950	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.805	OR			
1449714526	rs2551038	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.358	OR			
1449714526	rs2551038	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.394	OR			
1449714519	rs3852209	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.281	OR			
1449714519	rs3852209	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.952	OR			
1449714559	rs4264931	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.059	OR			
1449714559	rs4264931	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.950	OR			
1449714566	rs2068190	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.517	OR			
1449714566	rs2068190	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.952	OR			
1449714552	rs1971431	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.160	OR			
1449714552	rs1971431	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.782	OR			
1446896105	rs2511398	Selective serotonin reuptake inhibitors	Efficacy	no	Allele G is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele A.			= 2.28E-5	OR	1.51		
1446896003	rs7802493	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.			= 9.35E-7	OR			
1449714590	rs12720071	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.059	OR			
1449714590	rs12720071	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.696	OR			
1449714573	rs1862342	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	T		= 0.387	OR			
1449714573	rs1862342	opioids	Dosage	no	Allele T is not associated with dose of opioids in people with Pain as compared to allele C.	T		= 0.590	OR			
1449714583	rs806368	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.590	OR			
1449714583	rs806368	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.779	OR			
1449714623	rs1799971	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	G		= 0.175	OR			
1449714623	rs1799971	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	G		= 0.519	OR			
1449714630	rs9479757	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.301	OR			
1449714630	rs9479757	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.429	OR			
1449714658	rs1323042	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	G		= 0.203	OR			
1449714658	rs1323042	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	G		= 0.576	OR			
1449714665	rs618207	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.635	OR			
1449714665	rs618207	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.905	OR			
1449714637	rs540825	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.520	OR			
1449714637	rs540825	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele T.	A		= 0.845	OR			
1449714644	rs562859	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.586	OR			
1449714644	rs562859	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.736	OR			
981419976	rs2032582	antipsychotics	Efficacy	not stated	Allele C is associated with increased response to antipsychotics in people with Schizophrenia.	A	A	= 0.05	Unknown			
1451411060	rs1051792	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + AG.			= 0.014	OR	3.06	1.17	8.66
1449714651	rs548646	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.868	OR			
1449714651	rs548646	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.894	OR			
1451411069	rs1051792	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes AA + GG.			= 0.004	OR	4.65	1.49	19.33
1450812440	rs1799971	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.			= 0.93				
1449714698	rs1045642	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.145	OR			
1449714698	rs1045642	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.423	OR			
1445585209	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to genotypes CC + CT.	C		= 0.012	OR			
1450812447	rs1799971	opioids	Dosage	not stated	Genotype GG is associated with increased dose of opioids in people with Pain as compared to genotypes AA + AG.			= 0.018				
1449714672	rs639855	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.407	OR			
1449714672	rs639855	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.715	OR			
1449714679	rs497976	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.528	OR			
1449714679	rs497976	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.867	OR			
1449714719	rs2235033	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.229	OR			
1449714719	rs2235033	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.870	OR			
1449714726	rs1128503	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.014	OR			
1449714726	rs1128503	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.544	OR			
1449714705	rs4437575	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.160	OR			
1449714705	rs4437575	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.444	OR			
1449714712	rs2235013	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.172	OR			
1449714712	rs2235013	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.873	OR			
1451416180	rs6311	antidepressants	Efficacy	no	Genotypes CC + CT is associated with increased response to antidepressants in people with Bipolar Disorder, Depression or Depressive Disorder, Major as compared to genotype TT.			= 0.003	OR	1.4	1.12	1.76
1451416269	rs6313	antidepressants	Efficacy	yes	Genotypes AA + AG is associated with increased response to antidepressants in people with Bipolar Disorder, Depression or Depressive Disorder, Major as compared to genotype GG.			= 0.04	OR	1.31	1.02	1.68
1451416269	rs6313	antidepressants	Efficacy	yes	Genotypes AA + AG is associated with increased response to antidepressants in people with Bipolar Disorder, Depression or Depressive Disorder, Major as compared to genotype GG.			= 0.05	OR	1.28	1.0	1.62
1451416321	rs7997012	antidepressants	Efficacy	no	Genotype GG is associated with increased response to antidepressants in people with Bipolar Disorder, Depression or Depressive Disorder, Major as compared to genotype AA.			< 0.0001	OR	2.2	1.53	3.16
1184754493	CYP2D6 poor metabolizer	antipsychotics	Efficacy	not stated	CYP2D6 poor metabolizer is not associated with response to antipsychotics in people with Psychotic Disorders as compared to CYP2D6 intermediate metabolizer and normal metabolizer.				OR	1.59	0.77	3.26
1451431406	rs1061622	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele T is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele G.			= 0.001	OR	2.62	1.52	4.51
1451431240	rs1801274	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele A is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.			= 0.038	OR	1.26	1.01	1.56
1451431260	rs396991	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Spondylarthritis as compared to allele A.			= 0.01	OR	6.83	1.59	29.37
1451431289	rs361525	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele A.			= 0.03	OR	5.1	1.76	14.83
1451431360	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid, Autoimmune Diseases or Psoriasis as compared to allele A.			= 0.001	OR	1.66	1.22	2.24
1451431360	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid, Autoimmune Diseases or Psoriasis as compared to allele A.			= 0.004	OR	3.08	1.44	6.63
1451431360	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid, Autoimmune Diseases or Psoriasis as compared to allele A.			= 0.022	OR	1.85	1.09	3.15
1451431400	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele T.			= 0.003	OR	2.24	1.32	3.8
1451544786	rs1801253	Beta Blocking Agents	Efficacy	yes	Allele C is associated with increased response to Beta Blocking Agents in children with Cardiomyopathy, Dilated as compared to allele G.			< 0.05				
1451544780	rs61767072	Beta Blocking Agents	Efficacy	yes	Allele del is associated with increased response to Beta Blocking Agents in children with Cardiomyopathy, Dilated as compared to allele GGGGCGGGGCCG.			< 0.05				
1451544792	rs1042713	Beta Blocking Agents	Efficacy	yes	Allele A is associated with increased response to Beta Blocking Agents in children with Cardiomyopathy, Dilated as compared to allele G.			< 0.05				
1451506720	rs139945292	Beta Blocking Agents	Efficacy	yes	Allele T is associated with decreased response to Beta Blocking Agents in people with Hypertension as compared to allele C.			= 6e-4	Unknown			
1449714757	rs553668	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.847	OR			
1449714757	rs553668	opioids	Dosage	no	Allele G is not associated with dose of opioids in people with Pain as compared to allele A.	A		= 0.965	OR			
1451732680	rs1800797	opioids	Dosage	yes	Allele A is associated with decreased dose of opioids in children with Neoplasms and Pain as compared to allele G.	A		= 0.047				
1451732688	rs1800629	opioids	Dosage	yes	Genotype GG is associated with increased dose of opioids in children with Neoplasms and Pain as compared to genotype AG.	A		= 0.031				
1451747900	rs2952768	opioids	Efficacy	yes	Genotype CC is associated with decreased response to opioids in people with Pain, Postoperative as compared to genotypes CT + TT.			= 8.04E-7				
1451747900	rs2952768	opioids	Efficacy	yes	Genotype CC is associated with decreased response to opioids in people with Pain, Postoperative as compared to genotypes CT + TT.			= 0.021				
1449714733	rs1202170	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.187	OR			
1449714733	rs1202170	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.923	OR			
1449714740	rs7802773	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.171	OR			
1449714740	rs7802773	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.259	OR			
1449714747	rs13229143	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.354	OR			
1449714747	rs13229143	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.600	OR			
1449714790	rs6279	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.571	OR			
1449714790	rs6279	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.703	OR			
1448259064	rs1801274	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis and Spondylitis, Ankylosing as compared to genotype AA.			= 0.027	OR	3.904	1.174	13.38
1448259064	rs1801274	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis and Spondylitis, Ankylosing as compared to genotype AA.			= 0.455	OR	0.621	0.178	2.17
1449714777	rs1554929	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.224	OR			
1449714777	rs1554929	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.965	OR			
699642186	rs10879346	antidepressants	Efficacy	yes	Allele C is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype TT.			= 0.003	OR	2.55	1.36	4.76
1449714827	rs17601612	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.204	OR			
1449714827	rs17601612	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele G.	C		= 0.575	OR			
1449714797	rs6275	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.690	OR			
1449714797	rs6275	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.712	OR			
1449714804	rs1125394	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.106	OR			
1449714804	rs1125394	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.904	OR			
1449714811	rs7131440	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.728	OR			
1449714811	rs7131440	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.858	OR			
1449714836	rs7131056	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	C		= 0.784	OR			
1449714836	rs7131056	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	C		= 0.845	OR			
1449714843	rs4648317	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.090	OR			
1449714843	rs4648317	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.270	OR			
1449714876	rs1176744	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	C		= 0.575	OR			
1449714876	rs1176744	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele A.	C		= 0.660	OR			
1449714883	rs2276307	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.443	OR			
1449714883	rs2276307	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.905	OR			
1449714862	rs11606194	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.378	OR			
1449714862	rs11606194	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.421	OR			
827804313	rs1045642	antiepileptics	Other	no	Allele G is not associated with response to antiepileptics in people with Epilepsy as compared to allele A.	A		= 0.17	OR	1.12	0.95	1.32
1449714869	rs7103572	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.573	OR			
1449714869	rs7103572	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.824	OR			
827804302	rs2032582	antiepileptics	Other	no	Allele C is not associated with response to antiepileptics in people with Epilepsy as compared to allele A.	A		= 0.96	OR	0.99	0.89	1.14
1449714911	rs1062613	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.451	OR			
1449714911	rs1062613	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.749	OR			
1449714918	rs2276302	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.064	OR			
1449714918	rs2276302	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.521	OR			
1449752300	rs3212986	Platinum compounds	Efficacy	yes	Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes AA + AC.	C		= 0.0268	OR	2.5	1.12	5.69
1449752308	rs25487	Platinum compounds	Efficacy	yes	Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotypes CT + TT.	C		= 0.0161	OR	2.99	1.26	7.62
1445296998	rs3794271	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes AG + GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.			= 0.00057	OR			
1449752387	rs11615	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.	A			OR			
1444707079	rs7772821	corticosteroids	Efficacy	yes	Genotype GG is associated with increased response to corticosteroids in people with Asthma as compared to genotypes GT + TT.			< 0.05	OR			
1449752415	rs1470383	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.	A			OR			
1449752421	rs1801131	Platinum compounds	Efficacy	no	Allele G is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele T.	G			OR			
1449752396	rs13181	Platinum compounds	Efficacy	no	Allele G is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele T.	G			OR			
655386544	rs1799732	antipsychotics	Efficacy	no	Allele G is not associated with response to antipsychotics in people with Schizophrenia as compared to allele del.				Unknown			
1449752404	rs1799793	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele T.	C			OR			
1448818544	rs4680	opioids	Dosage	yes	Genotype GG is associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotypes AA + AG.	A		= 0.015	OR			
1449752428	rs1801133	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.	A			OR			
1449752434	rs1799782	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.	A			OR			
608431157	rs3775291	Measles vaccines	Efficacy	yes	Genotype CT is associated with decreased response to Measles vaccines as compared to genotype CC.			= 0.02	Unknown			
827793156	rs2804400	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	T		= 0.89	OR	1.02	0.77	1.35
1448818810	rs1799971	opioids	Dosage	no	Genotypes AG + GG is associated with increased dose of opioids in people with Neoplasms and Pain as compared to genotype AA.	A		= 0.085	OR			
1445296437	rs6311	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.			> 0.05	OR			
1445296428	rs7997012	antidepressants	Efficacy	yes	Genotypes AG + GG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype AA.			= 0.044	OR	1.92	1.02	3.61
1451117080	CYP2D6 normal metabolizers	opioids	Efficacy	no	CYP2D6 normal metabolizers are associated with decreased response to opioids in people with Pain, Postoperative as compared to CYP2D6 intermediate metabolizers.			= 0.57				
1451117080	CYP2D6 normal metabolizers	opioids	Efficacy	no	CYP2D6 normal metabolizers are associated with decreased response to opioids in people with Pain, Postoperative as compared to CYP2D6 intermediate metabolizers.			= 0.83				
827777870	rs113420705	Immunoglobulins	Efficacy	yes	Genotypes CT + TT are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype CC.			= 0.031	OR	2.95	1.1	7.91
827777870	rs113420705	Immunoglobulins	Efficacy	yes	Genotypes CT + TT are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype CC.			= 0.095	OR	1.75	0.91	3.42
827777860	rs28493229	Immunoglobulins	Efficacy	yes	Genotypes CC + CG are associated with decreased response to Immunoglobulins in children with Mucocutaneous Lymph Node Syndrome as compared to genotype GG.	C		= 0.015	OR	2.13	1.15	3.92
1447987188	rs7756992	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.	A	G	= 0.001	OR			
1447987188	rs7756992	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.	A	G	= 0.002	OR			
1447987188	rs7756992	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.	A	G	= 0.008	OR			
1447987188	rs7756992	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele G is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele A.	A	G	= 0.02	OR			
1447987173	rs7754840	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele C is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele G.	C	G	= 0.01	OR			
1447987173	rs7754840	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele C is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele G.	C	G	= 0.01	OR			
1447987173	rs7754840	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele C is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele G.	C	G	= 0.02	OR			
1447987173	rs7754840	Dipeptidyl peptidase 4 (DPP-4) inhibitors	Efficacy	yes	Allele C is associated with increased response to Dipeptidyl peptidase 4 (DPP-4) inhibitors in people with Diabetes Mellitus as compared to allele G.	C	G	= 0.04	OR			
1184136041	rs2269577	Platinum compounds	Efficacy	no	Genotype CG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	C		= 0.113	OR	1.415	0.921	2.172
769170906	rs699	Antihypertensives	Efficacy	not stated	Allele G is not associated with response to Antihypertensives in people with Hypertension.				Unknown			
613978984	rs1042714	Beta Blocking Agents	Efficacy	no	Allele G is not associated with response to Beta Blocking Agents in people with Heart Failure as compared to allele C.				Unknown			
1446905073	rs1295686	Hepatitis vaccines	Efficacy	yes	Allele T is associated with decreased response to Hepatitis vaccines as compared to allele C.	C		= 0.044	OR	2.73	1.01	7.4
613979015	rs1801253	Beta Blocking Agents	Efficacy	no	Allele C is not associated with response to Beta Blocking Agents in people with Heart Failure as compared to allele G.				Unknown			
613979010	rs1801252	Beta Blocking Agents	Efficacy	no	Allele A is not associated with response to Beta Blocking Agents in people with Heart Failure as compared to allele G.				Unknown			
613979002	rs1800888	Beta Blocking Agents	Efficacy	no	Allele T is not associated with response to Beta Blocking Agents in people with Heart Failure as compared to allele C.				Unknown			
613978995	rs1042713	Beta Blocking Agents	Efficacy	no	Allele A is not associated with response to Beta Blocking Agents in people with Heart Failure as compared to allele G.				Unknown			
1447986304	rs3751664	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	T		= 0.48	OR	1.17	0.76	1.79
1447986286	rs3794619	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	C		= 0.06	OR	0.68	0.46	1.01
1447986298	rs11640796	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	G		= 0.16	OR	1.21	0.93	1.58
1447986292	rs7191246	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	G		= 0.04	OR	1.75	1.01	3.02
1447986272	rs12813888	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	C		= 0.24	OR	0.84	0.63	1.12
1450823183	rs1799971	opioids	Dosage	yes	Genotypes AG + GG are associated with increased dose of opioids in people with Pain, Postoperative as compared to genotype AA.			< 0.00001				
1450823183	rs1799971	opioids	Dosage	yes	Genotypes AG + GG are associated with increased dose of opioids in people with Pain, Postoperative as compared to genotype AA.			< 0.36				
1447986278	rs1054645	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	A		= 0.26	OR	0.8	0.54	1.18
1447986254	rs215976	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	C		= 0.016	OR	0.7	0.52	0.93
1447986266	rs216008	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	C		= 0.58	OR	0.92	0.7	1.21
1447986260	rs7316246	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	A		= 0.78	OR	0.89	0.58	1.35
1447986242	rs2248069	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	C		= 0.97	OR	0.97	0.75	1.27
1447986236	rs16030	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.	G		= 0.48	OR	0.86	0.58	1.29
1447986248	rs2239128	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	C		= 0.28	OR	1.16	0.89	1.5
1447986224	rs10416717	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.	A		= 0.92	OR	0.99	0.76	1.28
1447986230	rs7254351	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.	T		= 0.52	OR	0.91	0.7	1.2
1450823255	rs1045642	opioids	Dosage	no	Genotypes AA + AG are not associated with dose of opioids in people with Pain as compared to genotype GG.			< 0.82				
1447986214	rs2074880	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.	C		= 0.40	OR	1.12	0.86	1.45
1447986196	rs2075650	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.				OR			
1447986178	rs2231142	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.				OR			
1447986147	rs17171676	hmg coa reductase inhibitors	Efficacy	no	Allele C is associated with response to hmg coa reductase inhibitors as compared to allele A.			> 0.05	OR			
1447986147	rs17171676	hmg coa reductase inhibitors	Efficacy	no	Allele C is associated with response to hmg coa reductase inhibitors as compared to allele A.			< 1.0e4	OR			
1446904772	HLA-B*35:03:01	Rubella vaccines	Efficacy	yes	HLA-B *35:03:01 is associated with increased response to Rubella vaccines in children.			= 0.031	OR			
1446904778	HLA-C*15:02:01	Rubella vaccines	Efficacy	yes	HLA-C *15:02:01 is associated with increased response to Rubella vaccines in children.			= 0.035	OR			
1447674771	rs10490162	antipsychotics	Efficacy	yes	Genotype TT is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CC + CT.			< 0.05	OR			
1447674758	rs12467557	antipsychotics	Efficacy	yes	Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.			< 0.05	OR			
1446904338	HLA-B*44:02:01:01	Measles vaccines	Efficacy	yes	HLA-B *44:02:01:01 is associated with response to Measles vaccines in children.				OR	0.34	0.15	0.79
1446904346	HLA-DRB1*01:01:01	Measles vaccines	Efficacy	yes	HLA-DRB1 *01:01:01 is associated with response to Measles vaccines in children.				OR	0.43	0.2	0.91
982035563	rs2239050	calcium channel blockers	Efficacy	yes	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotypes CC + CG.	C		= 1.1E-4	Unknown			
1446904352	HLA-DRB1*08:01:01	Measles vaccines	Efficacy	yes	HLA-DRB1 *08:01:01 is associated with response to Measles vaccines in children.				OR	0.24	0.07	0.76
1446904358	HLA-DQA1*01:04:01:01	Measles vaccines	Efficacy	yes	HLA-DQA1 *01:04:01:01 is associated with increased response to Measles vaccines in children.				OR	6.67	1.51	29.4
1184137425	rs1799782	Platinum compounds	Efficacy	yes	Genotypes AA + AG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			< 0.01	OR	2.32	1.27	4.25
1184137425	rs1799782	Platinum compounds	Efficacy	yes	Genotypes AA + AG is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			= 0.01	OR	6.43	2.01	20.02
1184137507	rs2234767	Platinum compounds	Efficacy	no	Genotypes AA + AG is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			> 0.05	OR	1.63	0.88	3.02
1184137499	rs763110	Platinum compounds	Efficacy	no	Genotypes CC + CT is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.			> 0.05	OR	1.02	0.28	3.68
1447678146	rs1333049	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.			= 0.28	OR	1.27	0.82	1.98
1447678134	rs10120688	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.			= 0.19	OR	0.76	0.51	1.15
1447678108	rs3807598	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.			= 0.92	OR	0.98	0.63	1.53
1446908047	rs12817819	Antihypertensives	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.			= 1.6E-6	OR	1.65	1.36	1.95
1446908047	rs12817819	Antihypertensives	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.			= 6.31E-6	OR	1.63	1.29	1.98
1446908047	rs12817819	Antihypertensives	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.	T		= 7.69E-4	OR	1.76	1.27	2.44
1446908047	rs12817819	Antihypertensives	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.	T		= 0.0024	OR	1.57	1.17	2.01
1446908047	rs12817819	Antihypertensives	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to Antihypertensives in people with Coronary Artery Disease or Hypertension as compared to genotype CC.	T		= 0.1044	OR	1.73	0.74	4.04
1447678116	rs5883064	Platinum compounds	Efficacy	no	Allele CT is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele del.			= 0.82	OR	0.95	0.63	1.45
1447678122	rs1859168	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele C.			= 0.75	OR	0.93	0.61	1.43
1447678081	rs4759314	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.			= 0.66	OR	0.89	0.51	1.53
1446908024	rs6465084	antipsychotics	Toxicity	yes	Genotype AA is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.			= 0.046	OR			
1447678060	rs2107425	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.			= 0.77	OR	0.94	0.63	1.41
1449165300	rs1319501	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.517	OR	0.765	0.33	1.72
1449165300	rs1319501	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.557	OR	0.84	0.72	1.76
1449165300	rs1319501	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.660	OR	1.12	0.67	1.85
1449165300	rs1319501	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.728	OR	1.1	0.63	1.92
1449165313	rs3801266	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.213	OR	1.34	0.84	2.15
1449165313	rs3801266	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.224	OR	1.29	0.85	1.97
1449165313	rs3801266	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.768	OR	1.11	0.55	2.23
1449165313	rs3801266	Antihypertensives	Efficacy	no	Allele C is not associated with response to Antihypertensives in women with Pregnancy as compared to allele T.			= 0.804	OR	1.06	0.64	1.75
1447678000	rs7958904	Platinum compounds	Efficacy	yes	Genotypes CC + CG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.	C	C	= 0.01	OR	0.62	0.42	0.9
1447677984	rs2839698	Platinum compounds	Efficacy	yes	Genotypes AA + AG are associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotype GG.	A	A	= 0.04	OR	1.48	1.01	2.18
1447677992	rs619586	Platinum compounds	Efficacy	yes	Genotypes AG + GG are associated with decreased response to Platinum compounds in people with Lung Neoplasms as compared to genotype AA.	A	A	= 0.04	OR	0.6	0.36	0.97
1447677963	rs6983267	Platinum compounds	Efficacy	yes	Genotypes GG + GT are associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotype TT.	G	G	= 0.02	OR	1.64	1.08	2.49
827845755	rs4148157	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.			= 0.73	OR	1.06	0.77	1.45
827845746	rs2231148	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.94	OR	1.01	0.74	1.38
1446907782	rs3846662	hmg coa reductase inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in women with familial hypercholesterolemia as compared to allele G.			< 0.05	OR			
827845737	rs2622628	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 0.48	OR	1.14	0.79	1.65
827845728	rs2725256	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.			= 0.35	OR	1.16	0.84	1.59
827845705	rs2231142	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.			= 0.89	OR	1.02	0.76	1.37
827845684	rs17731538	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 0.39	OR	1.34	0.66	2.83
827845129	rs2231137	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.27	OR	1.17	0.88	1.56
827845123	rs3109823	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.17	OR	1.25	0.89	1.75
827845117	rs17731799	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.59	OR	1.08	0.81	1.44
827845112	rs3219191	antiepileptics	Efficacy	no	Allele del is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele TGAG.			= 0.38	OR	1.13	0.85	1.51
827845107	rs3114020	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.4	OR	1.13	0.85	1.5
769168996	rs533556	hmg coa reductase inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.			= 0.021	Unknown			
769168996	rs533556	hmg coa reductase inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.			= 0.989	Unknown			
769168989	rs1532624	hmg coa reductase inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.			= 0.006	Unknown			
769168989	rs1532624	hmg coa reductase inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to hmg coa reductase inhibitors in people with Hyperlipidemias as compared to genotype CC.			= 0.006	Unknown			
769168986	rs1800497	antipsychotics	Efficacy	no	Allele A is not associated with response to antipsychotics in people with Schizophrenia as compared to allele G.				Unknown			
769168983	rs1799732	antipsychotics	Efficacy	yes	Allele del is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.			= 0.03	OR	0.65	0.43	0.97
827845075	rs1000002	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.63	OR	1.07	0.81	1.42
827845069	rs8180093	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 1.0	OR	1.0	0.64	1.57
827845063	rs2139560	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.			= 0.44	OR	1.15	0.79	1.68
827845057	rs3805111	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 0.46	OR	1.18	0.75	1.86
827845051	rs3792581	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.25	OR	1.2	0.86	1.68
827845045	rs2293001	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.11	OR	1.3	0.93	1.83
827845039	rs2293001	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.11	OR	1.3	0.93	1.83
827845032	rs4148572	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.29	OR	1.2	0.85	1.69
827845025	rs4148557	antiepileptics	Efficacy	no	Allele G is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 0.95	OR	1.01	0.64	1.61
827845000	rs3740066	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.89	OR	1.02	0.77	1.35
827844993	rs3758395	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele C.			= 0.52	OR	1.09	0.84	1.4
827844971	rs2273697	antiepileptics	Efficacy	no	Allele A is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele G.			= 0.31	OR	1.21	0.83	1.76
1447677374	rs4775936	triglycerides	Other	yes	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	C	T	= 0.00028	OR			
981477503	rs2240017	corticosteroids	Efficacy	yes	Genotype CG is associated with increased response to corticosteroids in children with Asthma as compared to genotype CC.	G		= 1.0E-4	Unknown			
1447677364	rs700518	triglycerides	Other	yes	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele A.	C		= 0.00019	OR			
981477511	rs6314	antidepressants	Efficacy	yes	Genotypes AG + GG are associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype AA.			= 0.023	Unknown			
1184167140	rs7124442	antidepressants	Efficacy	no	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	C		= 0.322	OR			
1184167136	rs6265	antidepressants	Efficacy	no	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	T		= 0.8205	OR			
1447677354	rs3759811	triglycerides	Other	yes	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	C	T	= 0.00045	OR			
1184167131	rs7103411	antidepressants	Efficacy	no	Genotype CC is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CT + TT.	C		= 0.4422	OR			
1447677307	rs10046	triglycerides	Other	yes	Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G.	A	G	= 0.0000069	OR			
1447677286	rs2289105	triglycerides	Other	yes	Allele C is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele T.	C	T	= 0.0000074	OR			
1447677221	rs749292	triglycerides	Other	yes	Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G.	A	G	= 0.000037	OR			
981475658	rs430397	Platinum compounds	Efficacy	yes	Genotype TT is associated with increased resistance to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype CC.	C		= 0.019	Unknown			
1448266657	rs247616	hmg coa reductase inhibitors	Efficacy	yes	Allele T is associated with increased response to hmg coa reductase inhibitors as compared to allele C.	T		= 8.52E-13	OR			
1184511758	rs861539	Platinum compounds	Efficacy	not stated	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.				HR	0.939	0.651	1.356
1184511758	rs861539	Platinum compounds	Efficacy	not stated	Allele A is not associated with response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.				HR	0.96	0.539	1.71
1451099900	rs11749255	Antihypertensives	Efficacy	no	Allele A is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele G.			= 3.8E-8	OR	1.6	1.3	1.9
1451099900	rs11749255	Antihypertensives	Efficacy	no	Allele A is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele G.			= 4.4E-5	OR	2.0	1.4	2.8
1451099900	rs11749255	Antihypertensives	Efficacy	no	Allele A is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele G.			= 7.3E-5	OR	1.5	1.2	1.8
1184511789	rs861539	Platinum compounds	Efficacy	not stated	Allele A is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.				OR	1.509	1.099	2.072
1451100040	rs6487504	Antihypertensives	Efficacy	no	Allele T is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele C.			= 1.6E-7	OR	1.81	1.4	2.3
1451100040	rs6487504	Antihypertensives	Efficacy	no	Allele T is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele C.			= 1.1E-5	OR	1.9	1.4	2.5
1451100040	rs6487504	Antihypertensives	Efficacy	no	Allele T is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele C.			= 4E-3	OR	1.7	1.2	2.5
1447680238	rs361525	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis and Spondylarthropathies as compared to allele A.			= 0.011	OR	2.208	1.197	4.074
1447680238	rs361525	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis and Spondylarthropathies as compared to allele A.			= 0.016	OR	2.196	1.161	4.154
1447680222	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis or Spondylarthropathies as compared to allele A.			= 0.000086	OR	2.005	1.417	2.838
1447680222	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis or Spondylarthropathies as compared to allele A.			= 0.00012	OR	1.954	1.388	2.75
1448106204	rs11264359	Bisphosphonates	Efficacy	yes	Allele A is associated with increased response to Bisphosphonates in people with Osteoporosis as compared to allele G.			= 0.01	OR			
1448106156	rs2297480	Bisphosphonates	Efficacy	yes	Allele T is associated with increased response to Bisphosphonates in people with Osteoporosis as compared to allele G.			= 0.01	OR			
1183705675	rs1050828	artemisinin and derivatives	Efficacy	no	Allele T is not associated with response to artemisinin and derivatives in people with Malaria, Falciparum as compared to allele C.			= 0.685	OR			
1183689377	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes CT + TT.			= 0.01	OR	2.17	1.17	4.03
1183689377	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes CT + TT.			= 0.01	OR	3.36	1.35	9.92
1183689377	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype CC is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes CT + TT.			= 0.05	OR	3.38	1.0	11.48
1450973900	rs429358	hmg coa reductase inhibitors	Efficacy	yes	Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Alzheimer Disease as compared to genotypes CT + TT.			< 0.01				
1450973900	rs429358	hmg coa reductase inhibitors	Efficacy	yes	Genotype CC is associated with increased response to hmg coa reductase inhibitors in people with Alzheimer Disease as compared to genotypes CT + TT.							
1184754414	rs7999812	Platinum compounds	Efficacy	no	Allele C is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele A.	C	C	> 0.05	OR			
1184754389	rs9535826	Platinum compounds	Efficacy	yes	Allele G is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	G	G	= 0.01	OR	2.05	1.19	3.52
1449155370	rs352139	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes CT + TT is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	C		= 0.017	OR	2.17	1.15	4.09
1184754410	rs1061472	Platinum compounds	Efficacy	no	Allele T is not associated with resistance to Platinum compounds in people with Lung Neoplasms as compared to allele C.	T	T	> 0.05	OR			
1184754406	rs9535828	Platinum compounds	Efficacy	yes	Allele A is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to allele G.	A	A	= 0.01	OR	1.96	1.17	3.3
1449155414	rs11465996	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes CG + GG is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	G		= 0.0044	OR	0.33	0.15	0.71
1449155420	rs11938228	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes AA + AC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.	A		= 0.0019	OR	0.3	0.14	0.64
1449155430	rs4696480	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes AT + TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype AA.	A		= 0.0032	OR	0.22	0.08	0.59
1447679474	rs6356	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	C	C	= 0.523	OR			
1447679454	rs2550956	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	G	G	= 0.792	OR			
1447679460	rs10743152	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	C	C	= 0.199	OR			
1447679466	rs10770141	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	A	= 0.275	OR			
1447679420	rs2242446	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.	C	C	= 0.928	OR			
1447679428	rs5564	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	A	= 0.905	OR			
1447679434	rs140504	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	A	= 0.515	OR			
1447679410	rs1362621	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	A	= 0.610	OR			
1447679388	rs7131056	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	A	A	= 0.090	OR			
1447679401	rs2234689	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	C	C	= 0.231	OR			
1447679373	rs3863145	Selective serotonin reuptake inhibitors	Efficacy	no	Genotype GG is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes AA + AG.	A	A	= 0.939	OR			
1447679379	rs4963126	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	A	= 0.180	OR			
1447679358	rs1800544	Selective serotonin reuptake inhibitors	Efficacy	yes	Genotype CG is associated with increased response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes CC + GG.	C	C	= 0.042	OR	6.38	1.53	18.71
981483816	rs1568885	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	no	Allele A is associated with response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid.				Unknown			
1450368353	rs3842761	Platinum compounds	Efficacy	yes	Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms.	C	C	= 0.049	OR			
1447678861	rs4627835	antipsychotics	Dosage	yes	Allele T is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele A.			= 0.02	OR			
1448612748	rs13144136	Antihypertensives	Efficacy	yes	Allele G is associated with increased response to Antihypertensives in people with Hypertension as compared to allele T.	G		= 1.00E-6	OR	0.68	0.58	0.8
1448612748	rs13144136	Antihypertensives	Efficacy	yes	Allele G is associated with increased response to Antihypertensives in people with Hypertension as compared to allele T.	G		= 7.42E-6	OR	0.66	0.54	0.79
1447678850	rs16860087	antipsychotics	Dosage	yes	Allele A is associated with increased dose of antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to allele C.			= 0.02	OR			
827864486	rs2230345	Beta Blocking Agents	Efficacy	not stated	Genotypes AA + AT are associated with response to Beta Blocking Agents in people with Heart Failure as compared to genotype TT.			= 1.84E-4	Unknown			
1451221008	rs4680	opioids	Dosage	yes	Genotype GG is associated with increased dose of opioids in women with Breast Neoplasms and Pain, Postoperative as compared to genotypes AA + AG.	G		< 0.003				
1449271593	rs1799971	opioids	Efficacy	yes	Genotype AG is associated with decreased response to opioids in people with Pain, Postoperative as compared to genotype AA.	G		< 0.01	OR			
827815479	rs1800795	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to allele C.			< 0.05	OR	2.0	1.19	3.38
1183703365	rs1045642	antiepileptics	Efficacy	yes	Genotype AG is associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype GG.	G		= 0.03	OR	2.422	1.082	5.57
981939599	rs12082710	antidepressants	Efficacy	yes	Genotype TT is associated with increased response to antidepressants in people with Depression as compared to genotypes CC + CT.			= 0.044	OR	0.65	0.51	0.82
1446895666	rs1468412	antipsychotics	Efficacy	yes	Genotypes AA + AT is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	12.4	3.69	41.69
1446895666	rs1468412	antipsychotics	Efficacy	yes	Genotypes AA + AT is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	11.21	3.3	38.12
1446895666	rs1468412	antipsychotics	Efficacy	yes	Genotypes AA + AT is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	13.5	3.03	121.61
1446895651	rs165854	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	12.4	3.69	41.69
1446895651	rs165854	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	11.21	3.3	38.12
1446895651	rs165854	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with decreased response to antipsychotics in people with Schizophrenia.			< 0.0001	OR	13.5	3.03	121.61
1447944175	rs138337	corticosteroids	Efficacy	yes	Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele A.			= 0.003	OR	1.33	1.11	1.6
1446895571	rs6465084	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype AA.			= 0.009	OR	0.33	0.15	0.76
1446895571	rs6465084	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype AA.			= 0.019	OR	0.29	0.1	0.82
1446895571	rs6465084	antipsychotics	Efficacy	yes	Genotypes AG + GG is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotype AA.			= 0.029	OR	0.43	0.2	0.92
1446895589	rs10211524	antipsychotics	Efficacy	yes	Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.			= 0.023	OR	3.33	1.18	9.37
1446895589	rs10211524	antipsychotics	Efficacy	yes	Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.			= 0.029	OR	3.11	1.12	8.64
1446895589	rs10211524	antipsychotics	Efficacy	yes	Genotype AA is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotypes AG + GG.			= 0.047	OR	3.67	1.02	13.29
1447944114	rs138335	corticosteroids	Efficacy	yes	Allele G is associated with decreased response to corticosteroids in children with Asthma as compared to allele C.			= 0.01	OR	1.35	1.07	1.69
1446895550	rs1529461	antipsychotics	Efficacy	yes	Genotypes AA + AG is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.			= 0.006	OR	3.57	1.44	8.88
1446895550	rs1529461	antipsychotics	Efficacy	yes	Genotypes AA + AG is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.			= 0.013	OR	2.46	1.21	5.01
1446895550	rs1529461	antipsychotics	Efficacy	yes	Genotypes AA + AG is associated with decreased response to antipsychotics in people with Schizophrenia as compared to genotype GG.			= 0.018	OR	2.43	1.16	5.08
1446895561	rs2299214	antipsychotics	Efficacy	yes	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CT + TT.			= 0.031	OR	0.18	0.04	0.85
1446895561	rs2299214	antipsychotics	Efficacy	yes	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CT + TT.			= 0.041	OR	0.31	0.1	0.95
1446895561	rs2299214	antipsychotics	Efficacy	yes	Genotype CC is associated with increased response to antipsychotics in people with Schizophrenia as compared to genotypes CT + TT.			= 0.047	OR	0.32	0.1	0.98
1448107943	rs854547	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	no	Allele A is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele G.	A		= 0.1	OR	3.6	1.5	9.3
1184998157	rs1954787	antidepressants	Efficacy	yes	Genotype CC is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotype TT.			= 0.007	OR	1.45	1.107	1.913
1444929377	rs2069705	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.			= 0.0075	OR			
1444929377	rs2069705	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele G is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to allele A.			= 0.009	OR			
1183703910	rs889895	antidepressants	Efficacy	yes	Genotype GG is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.	G		= 0.02	OR			
1444880046	rs700518	Enzyme inhibitors	Other	yes	Genotype CC is associated with response to Enzyme inhibitors in women with Breast Neoplasms as compared to genotypes CC + CT.			= 0.01	OR			
1444880046	rs700518	Enzyme inhibitors	Other	yes	Genotype CC is associated with response to Enzyme inhibitors in women with Breast Neoplasms as compared to genotypes CC + CT.			= 0.03	OR			
1183703934	rs6928	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.			> 0.05	OR			
1183703934	rs6928	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	G		> 0.05	OR			
1184998246	rs1954787	antidepressants	Efficacy	yes	Allele C is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele T.			= 0.018	OR	1.22	1.035	1.445
1183704035	rs13515	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.			> 0.05	OR			
1183704035	rs13515	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	T		> 0.05	OR			
1183704043	rs6740584	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.			> 0.05	OR			
1183704043	rs6740584	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C		> 0.05	OR			
1183704039	rs8136867	antidepressants	Efficacy	no	Allele A is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	G		> 0.05	OR			
1447681685	rs17716295	antipsychotics	Efficacy	yes	Allele A is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.	A		= 8.71E-3	OR	1.78	1.15	2.75
1447681665	rs1544938	antipsychotics	Efficacy	yes	Allele C is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele G.	C		= 7.68E-4	OR	0.36	0.19	0.65
1447681671	rs13250975	antipsychotics	Efficacy	yes	Allele G is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele A.	G		= 6.81E-3	OR	0.42	0.23	0.79
1447681648	rs4586	antipsychotics	Efficacy	yes	Allele T is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele C.	T		= 1.13E-3	OR	1.77	1.24	2.43
1447681659	rs2513265	antipsychotics	Efficacy	yes	Allele A is associated with increased response to antipsychotics in people with Schizophrenia as compared to allele T.	A		= 1.44E-3	OR	0.53	0.36	0.78
1447681639	rs4795893	antipsychotics	Efficacy	yes	Allele G is associated with decreased response to antipsychotics in people with Schizophrenia as compared to allele A.	G		= 7.62E-4	OR	1.79	1.27	2.52
1183704047	rs2254237	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.			> 0.05	OR			
1183704047	rs2254237	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C		> 0.05	OR			
1183704054	rs889895	antidepressants	Efficacy	no	Allele A is not associated with response to antidepressants in people with Mental Disorders as compared to allele G.			> 0.05	OR			
1448123619	rs1799782	Platinum compounds	Efficacy	yes	Genotypes AA + AG are associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			= 0.002	OR	0.54	0.37	0.8
1448123553	rs25487	Platinum compounds	Efficacy	yes	Genotypes CC + CT are associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.			= 0.001	OR	0.74	0.62	0.89
1448123553	rs25487	Platinum compounds	Efficacy	yes	Genotypes CC + CT are associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype TT.			= 0.028	OR	0.72	0.53	0.96
981479921	rs6311	Selective serotonin reuptake inhibitors	Efficacy	no	Allele C is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele T.			= 0.62	Unknown			
981479928	rs7997012	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.			= 0.46	Unknown			
1444698865	rs1412125	Platinum compounds	Efficacy	yes	Genotype CC is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CT + TT.	C		= 0.013	OR	3.08	1.26	7.54
1444698874	rs2249825	Platinum compounds	Efficacy	yes	Genotype GG is associated with increased response to Platinum compounds in people with Lung Neoplasms as compared to genotypes CC + CG.	G		= 0.03	OR	10.63	1.26	89.58
1444698889	rs1045411	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	T			OR			
1444698904	rs7686909	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	C			OR			
1447680625	rs1042713	selective beta-2-adrenoreceptor agonists	Efficacy	no	Allele A is not associated with response to selective beta-2-adrenoreceptor agonists in children with Asthma as compared to genotype GG.			= 0.95	OR	1.01	0.79	1.28
1447680633	rs1042713	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in children with Asthma as compared to genotype GG.			= 0.18	OR	1.11	0.95	1.31
827784936	rs28364072	corticosteroids	Dosage	yes	Allele G is associated with increased dose of corticosteroids in children Asthma as compared to allele A.			= 0.002	OR	2.46	1.38	4.39
1183688854	rs588076	calcium channel blockers	Efficacy	yes	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype CC.			< 0.0001	OR			
1444698493	rs25487	Platinum compounds	Efficacy	yes	Genotypes CT + TT is associated with decreased response to Platinum compounds in people with Colorectal Neoplasms and Stomach Neoplasms as compared to genotype CC.			= 0.008	OR	0.62	0.44	0.89
1444698493	rs25487	Platinum compounds	Efficacy	yes	Genotypes CT + TT is associated with decreased response to Platinum compounds in people with Colorectal Neoplasms and Stomach Neoplasms as compared to genotype CC.			= 0.022	OR	0.73	0.55	0.96
1444698493	rs25487	Platinum compounds	Efficacy	yes	Genotypes CT + TT is associated with decreased response to Platinum compounds in people with Colorectal Neoplasms and Stomach Neoplasms as compared to genotype CC.			= 0.048	OR	0.68	0.46	1.0
1444698493	rs25487	Platinum compounds	Efficacy	yes	Genotypes CT + TT is associated with decreased response to Platinum compounds in people with Colorectal Neoplasms and Stomach Neoplasms as compared to genotype CC.			= 0.208	OR	0.78	0.53	1.15
1444698493	rs25487	Platinum compounds	Efficacy	yes	Genotypes CT + TT is associated with decreased response to Platinum compounds in people with Colorectal Neoplasms and Stomach Neoplasms as compared to genotype CC.			= 0.713	OR	0.92	0.6	1.42
1451284760	rs405509	Selective serotonin reuptake inhibitors	Efficacy	yes	Genotype TT is associated with increased response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to genotypes GG + GT.			= 0.04				
1183688944	rs10898815	calcium channel blockers	Efficacy	yes	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype AA.			< 0.0001	OR			
1183688940	rs2429427	calcium channel blockers	Efficacy	yes	Genotype GG is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotype AA.			< 0.0001	OR			
982028611	rs6265	antidepressants	Efficacy	yes	Genotype CT is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to genotypes CC + TT.			= 0.006	OR	1.26	1.07	1.48
1450943742	rs36217263	Beta Blocking Agents	Efficacy	yes	Genotypes A/del + del/del are associated with decreased response to Beta Blocking Agents in people with Hypertension as compared to genotype AA.			= 0.002	OR	4.77	1.76	12.94
1449715034	rs7208257	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.023	OR			
1449715034	rs7208257	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.141	OR			
1448258061	rs4980524	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.356	OR			
1449714818	rs7122246	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.449	OR			
1449714818	rs7122246	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.466	OR			
1451100046	rs324498	Antihypertensives	Efficacy	no	Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.			= 1.3E-6	OR	1.62	1.3	2.0
1451100046	rs324498	Antihypertensives	Efficacy	no	Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.			= 3.4E-5	OR	1.62	1.3	2.0
1451100046	rs324498	Antihypertensives	Efficacy	no	Allele G is associated with decreased response to Antihypertensives in people with Hypertension as compared to allele A.			= 0.01	OR	1.63	1.1	2.4
1449714354	rs3773679	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.675	OR			
1449714354	rs3773679	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.912	OR			
827844985	rs17222589	antiepileptics	Efficacy	no	Allele C is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele T.			= 0.39	OR	3.21	0.32	159.0
827844958	rs2804398	antiepileptics	Efficacy	no	Allele T is not associated with resistance to antiepileptics in people with Epilepsy as compared to allele A.			= 0.75	OR	1.05	0.74	1.49
1449714533	rs3864283	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.272	OR			
1449714533	rs3864283	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	C		= 0.716	OR			
982046448	rs3212986	Platinum compounds	Efficacy	no	Allele C is not associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.			= 0.54	OR	1.43	0.045	4.58
982028876	rs1045642	antidepressants	Efficacy	no	Genotype GG is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to genotypes AA + AG.			= 0.62	OR	0.93	0.72	1.22
1184136036	rs2269577	Platinum compounds	Efficacy	yes	Genotype CC is associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.	C		= 0.042	OR	2.135	1.026	4.441
1183704069	rs8136867	antidepressants	Efficacy	yes	Genotype AG is associated with increased response to antidepressants in people with Mental Disorders.			= 0.01	OR			
769257607	rs1045642	antiepileptics	Efficacy	no	Allele A is not associated with response to antiepileptics in people with Epilepsy as compared to allele G.				Unknown			
1183703357	rs1045642	antiepileptics	Efficacy	yes	Genotype AA is associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype GG.	G		< 0.001	OR	2.34	1.942	11.32
1183703357	rs1045642	antiepileptics	Efficacy	yes	Genotype AA is associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype GG.	G		< 0.001	OR	5.62	2.01	15.7
1183703357	rs1045642	antiepileptics	Efficacy	yes	Genotype AA is associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype GG.	G		= 0.02	OR	10.0	1.28	78.1
1448257695	rs38010	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele C.			= 0.424	OR			
1444698898	rs6832850	Platinum compounds	Efficacy	no	Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T.	A			OR			
1447678071	rs1899663	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele A.			= 0.13	OR	0.73	0.49	1.09
1447679448	rs2292023	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele C.	A	A	= 0.981	OR			
1446896652	CYP2D6 poor metabolizers	antidepressants	Dosage	no	CYP2D6 poor metabolizers are not associated with response to antidepressants in people with as compared to CYP2D6 normal metabolizer and ultra-metabolizer.				OR			
1446905079	rs1805015	Hepatitis vaccines	Efficacy	yes	Allele C is associated with increased response to Hepatitis vaccines as compared to allele T.	C		= 0.032	OR	0.08	0.01	0.8
1446896031	rs1438692	Selective serotonin reuptake inhibitors	Efficacy	no	Allele A is not associated with response to Selective serotonin reuptake inhibitors in people with Depressive Disorder, Major as compared to allele G.	A	G	= 4.42E-6	OR			
1448259006	rs396991	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis or Spondylitis, Ankylosing as compared to allele A.			= 0.040	OR	3.308	1.053	10.39
1448259006	rs396991	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic, Crohn Disease, Psoriasis or Spondylitis, Ankylosing as compared to allele A.			= 0.480	OR	0.915	0.175	1.171
1447680253	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis and Spondylarthropathies as compared to allele T.			= 0.003	OR	1.889	1.245	2.866
1447680253	rs1799724	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Allele C is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease, Inflammatory Bowel Diseases, Psoriasis and Spondylarthropathies as compared to allele T.			= 0.013	OR	1.779	1.13	2.802
1447678102	rs116907618	Platinum compounds	Efficacy	no	Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele G.			= 0.30	OR	0.76	0.45	1.27
1447943994	rs4149056	hmg coa reductase inhibitors	Efficacy	yes	Allele C is associated with decreased response to hmg coa reductase inhibitors in people with Cardiovascular Diseases as compared to allele T.	C		< 0.001	OR			
1447986186	rs10455872	hmg coa reductase inhibitors	Efficacy	yes	Allele G is associated with decreased response to hmg coa reductase inhibitors as compared to allele A.				OR			
1448258044	rs2701528	corticosteroids	Efficacy	no	Allele G is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.428	OR			
1448258082	rs2282490	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.833	OR			
1448258435	rs2532292	corticosteroids	Efficacy	no	Allele T is not associated with response to corticosteroids in people with Asthma as compared to allele A.			= 0.908	OR			
1448258411	rs1052587	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.874	OR			
1447983254	rs2831440	antidepressants	Efficacy	yes	Allele T is associated with increased response to antidepressants in people with Depressive Disorder, Major as compared to allele G.	G		= 0.002327	OR	3.53		
1448123636	rs861539	Platinum compounds	Efficacy	yes	Genotypes AA + AG are associated with increased response to Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to genotype GG.			= 0.009	OR	0.69	0.52	0.91
1448258274	rs1396862	corticosteroids	Efficacy	no	Allele A is not associated with response to corticosteroids in people with Asthma as compared to allele G.			= 0.881	OR			
1448603797	rs1439050	antidepressants	Efficacy	no	Allele G is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	G			OR			
1448603909	rs3824519	antidepressants	Efficacy	no	Allele C is not associated with response to antidepressants in people with Depressive Disorder, Major as compared to allele T.	C			OR			
1448426798	rs2273697	antiepileptics	Efficacy	no	Genotypes AA + AG are not associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype GG.			= 0.83	OR	1.02	0.82	1.28
1448522700	rs6908425	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotypes CT + TT are associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotype CC.			= 0.013	OR	0.14	0.03	0.66
1448522639	rs9304742	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype CC is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Psoriasis as compared to genotypes CT + TT.			= 0.02	OR	7.66	1.37	42.7
1448424049	rs2606345	antiepileptics	Efficacy	yes	Genotype AA is associated with decreased response to antiepileptics in women with Epilepsy as compared to genotypes AC + CC.			= 0.000046	OR			
1449714442	rs6808122	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.366	OR			
1449714442	rs6808122	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.597	OR			
1449714485	rs7627615	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.344	OR			
1449714485	rs7627615	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.692	OR			
1449714932	rs1176713	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.361	OR			
1449714932	rs1176713	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.909	OR			
1448258104	rs2236647	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.701	OR			
1450368365	rs4244809	Platinum compounds	Efficacy	yes	Genotype GG is associated with decreased resistance to Platinum compounds in women with Ovarian Neoplasms as compared to genotypes AA + AG.	A	A	= 0.033	OR	0.3	0.1	0.91
1448258402	rs9468	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.858	OR			
1450823261	rs2032582	opioids	Dosage	no	Genotype CC is not associated with dose of opioids in people with Pain.			< 0.88				
1450372692	rs7905446	antidepressants	Efficacy	yes	Genotype TT is associated with decreased response to antidepressants in people with Depression as compared to genotypes GG + GT.			= 0.032	OR	1.385		
982035533	rs2239128	calcium channel blockers	Efficacy	yes	Allele C is associated with increased response to calcium channel blockers in people with Hypertension as compared to allele T.	C		= 0.011	Unknown			
1449714503	rs878567	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.118	OR			
1449714503	rs878567	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	A		= 0.525	OR			
1183689326	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes AA + AG.			= 0.0007	OR	2.14	1.38	3.33
1183689326	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes AA + AG.			= 0.002	OR	2.31	1.36	3.91
1183689326	rs1800629	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype GG is associated with increased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Inflammation as compared to genotypes AA + AG.			= 0.15	OR	2.83	0.69	11.6
1449714361	rs167771	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.050	OR			
1449714361	rs167771	opioids	Dosage	no	Allele A is not associated with dose of opioids in people with Pain as compared to allele G.	G		= 0.125	OR			
1296666803	rs352139	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes CC + CT.			= 0.04	OR	0.48	0.24	0.96
1296666803	rs352139	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype TT is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Crohn Disease or Inflammatory Bowel Diseases as compared to genotypes CC + CT.			= 0.04	OR	0.38	0.16	0.94
1448258238	rs242939	corticosteroids	Efficacy	no	Allele C is not associated with response to corticosteroids in people with Asthma as compared to allele T.			= 0.142	OR			
769169630	rs4796793	interferons	Efficacy	yes	Genotype GG is associated with increased response to interferons in people with Carcinoma, Renal Cell as compared to genotypes CC + CG.			= 0.0039	OR	8.38	1.63	42.96
1449714597	rs1049353	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.732	OR			
1449714597	rs1049353	opioids	Dosage	no	Allele C is not associated with dose of opioids in people with Pain as compared to allele T.	T		= 0.971	OR			
1448426774	rs717620	antiepileptics	Efficacy	yes	Genotypes CT + TT are associated with increased resistance to antiepileptics in people with Epilepsy as compared to genotype CC.			= 0.009	OR	1.24	1.06	1.46
982035593	rs2238032	calcium channel blockers	Efficacy	yes	Genotype TT is associated with increased response to calcium channel blockers in people with Hypertension as compared to genotypes GG + GT.	G		= 5.1E-12	Unknown			
1184997439	rs2900478	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.			= 1.22e-9	OR			
1184997439	rs2900478	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.	A		= 2.26e-6	OR			
1184997439	rs2900478	hmg coa reductase inhibitors	Efficacy	yes	Allele A is associated with decreased response to hmg coa reductase inhibitors as compared to allele T.	A		= 3.54e-3	OR			
1450933039	rs6920220	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic or Psoriasis as compared to genotypes AG + GG.			= 0.000				
1450933039	rs6920220	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic or Psoriasis as compared to genotypes AG + GG.			= 0.018				
1450933039	rs6920220	Tumor necrosis factor alpha (TNF-alpha) inhibitors	Efficacy	yes	Genotype AA is associated with decreased response to Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Psoriatic or Psoriasis as compared to genotypes AG + GG.			= 0.025				
1183698994	rs496503	antiepileptics	Efficacy	no	Allele A is not associated with response to antiepileptics in people with Epilepsy, Generalized as compared to allele G.			= 0.32	OR			
